Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of the Vivatmo proTM for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in Asthmatic Patients Responding to Inhaled Corticosteroid (ICS) Treatment

NCT05553379 is registered in ClinicalTrials.gov with Bosch Healthcare Solutions GmbH as lead sponsor.

NCT NCT05553379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05553379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of the Vivatmo proTM for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in Asthmatic Patients Responding to Inhaled Corticosteroid (ICS) Treatment
Lead sponsor
Bosch Healthcare Solutions GmbH
Phase
Observational
Overall status
Unknown status
Start date
March 15, 2022
Completion date
October 15, 2022
Enrollment
48 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

asthma